The authors hypothesized that “attrition of SASCs is a common feature of risk and development of lung fibrosis” and proposed that “the MUC5B variant potentially deregulates MUC5B silencing and locks in mucosecretory differentiation of SASC cells mobilized by injury”. Here, MUC5B is linked to pulmonary fibrosis.